| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/07/2003 | US6503935 Imidazoles and related compounds as α1A agonists |
| 01/07/2003 | US6503934 Substituted thiadiazolesulfonamides |
| 01/07/2003 | US6503931 Use of 4-amino pyridine for treatment of peripheral neuropathies |
| 01/07/2003 | US6503930 Pyrazole derivatives as p38 kinase inhibitors |
| 01/07/2003 | US6503929 Nitrate salt of anti-ulcer medicine |
| 01/07/2003 | US6503927 Amorphous paroxetine composition |
| 01/07/2003 | US6503925 Treating anxiety, anesthesia, and epilepsy |
| 01/07/2003 | US6503923 Haloalkoxy imidazonaphthyridines |
| 01/07/2003 | US6503920 Adminstering to treat progressive supranuclear palsy, Parkinson*s disease, and central nervous system disorders |
| 01/07/2003 | US6503919 Compounds of 7-oxo-2,3,7,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridin carboxylate |
| 01/07/2003 | US6503918 D-mannitol and its preparation |
| 01/07/2003 | US6503916 Treatment of ischemic brain injury |
| 01/07/2003 | US6503915 Use caffeine and alcohol following a stroke to reduce cerebral infarct damage and improve the chances for complete recovery |
| 01/07/2003 | US6503914 Thienopyrimidine-based inhibitors of the Src family |
| 01/07/2003 | US6503913 2-heterocyclically substituted dihydropyrimidines |
| 01/07/2003 | US6503911 Administering a sustained release pharmaceutical dosage form including ranolazine for therapy of cardiovascular disease selected from arrhythmias, variant and exercise-induced angina, and myocardial infarction |
| 01/07/2003 | US6503909 Administering as antiepileptic or anticonvulsant agents; treating central nervous system disorders with dihydrofolate reductase inhibitors; side effect reduction |
| 01/07/2003 | US6503908 Pharmaceutically active compounds |
| 01/07/2003 | US6503907 Indole and dihydroindole derivatives |
| 01/07/2003 | US6503906 Adjustment of dosage to age, sex, kidney function, and body weight |
| 01/07/2003 | US6503905 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 01/07/2003 | US6503903 Fab I inhibitors |
| 01/07/2003 | US6503900 [1,4]diazepino [6,7,1-jk ]carbazoles and derivatives |
| 01/07/2003 | US6503899 Azepino[4,5-b]pyrano[3,2-e]indoles |
| 01/07/2003 | US6503898 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection |
| 01/07/2003 | US6503897 N-Formylhydroxylamine derivatives; veterinary medicine; grampositive and gramnegative bacteria |
| 01/07/2003 | US6503895 Antigestagenically active steroids with a fluorinated 17α-alkyl chain |
| 01/07/2003 | US6503894 Pharmaceutical composition and method for treating hypogonadism |
| 01/07/2003 | US6503893 Method of treating hyperproliferative diseases using active vitamin D analogues |
| 01/07/2003 | US6503892 Method of using matrix metalloproteinase inhibitors in filtering blebs following glaucoma filtering surgery and in the treatment of ischemic damage to the retina and optic nerve |
| 01/07/2003 | US6503890 Aryl phosphate derivatives of d4T having anti-HIV activity |
| 01/07/2003 | US6503889 Especially capecitabine, gemcitabine, CPT-11 or pemetrexed |
| 01/07/2003 | US6503884 Administering fructopyranose sulfamate derivatives |
| 01/07/2003 | US6503882 Treatment of HIV |
| 01/07/2003 | US6503737 Isolated nucleic acids relating to the fkbA gene within the FK-520 polyketide synthase gene cluster |
| 01/07/2003 | US6503713 Methods for identifying RNA binding compounds |
| 01/07/2003 | US6503699 Method for photodecontamination of pathogens in blood using 5'-primary aminopsoralens |
| 01/07/2003 | US6503543 Tryptophan source from plants and uses therefor |
| 01/07/2003 | US6503536 Mixture with solvent and hydrophobic carrier |
| 01/07/2003 | US6503533 Antisense ogligonucleotides against Hepatitis B viral replication |
| 01/07/2003 | US6503529 Blood type methods and dietary supplements |
| 01/07/2003 | US6503523 In topical preparations for acne, skin aging, or skin whitening |
| 01/07/2003 | US6503513 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 01/07/2003 | US6503512 Anti-AIDS immunomodulator complex |
| 01/07/2003 | US6503507 Oxygen activatable formulations for disinfection or sterilization |
| 01/07/2003 | US6503506 Nutrient therapy for immuno-compromised patients |
| 01/07/2003 | US6503488 Acetylsalicylic acid, moisture barrier component, a silicone and solvent; free of aluminum compounds; nail hardeners, deodorants and sunscreens; safe |
| 01/07/2003 | US6503483 Dental formulation |
| 01/07/2003 | US6503482 Non-chlorofluorocarbon aerosol formulations |
| 01/07/2003 | US6503480 Aerodynamically light particles for pulmonary drug delivery |
| 01/07/2003 | US6502789 Flexible kite |
| 01/07/2003 | CA2229892C Liposome preparations of indolocarbazole derivatives |
| 01/07/2003 | CA2228524C Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating human malignancies |
| 01/07/2003 | CA2214845C Film-forming pharmaceutical composition for transdermic delivery |
| 01/07/2003 | CA2210365C New derivative of kojic acid and its use as a depigmenting agent |
| 01/07/2003 | CA2192481C Drug salts |
| 01/07/2003 | CA2149055C Antitumoral compositions containing taxan derivatives |
| 01/07/2003 | CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease |
| 01/07/2003 | CA2124784C Pentanoic acid derivatives |
| 01/07/2003 | CA2113363C Process for constructing a cdna library and a novel polypeptide and dna coding the same |
| 01/07/2003 | CA2093825C Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
| 01/07/2003 | CA2089666C Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 01/07/2003 | CA2075684C 1-acylpiperidine compounds |
| 01/07/2003 | CA2075590C Hydantoin derivatives |
| 01/07/2003 | CA2048245C Treatment of cataract with prostacyclin compounds |
| 01/07/2003 | CA2047531C 1-(substituted pyridinylamino)-1h-indol-5-yl substituted carbamates, a process and intermediates for their preparation and their use as medicaments |
| 01/06/2003 | WO2003004559A1 Composite particles, derived conjugates, preparation method thereof and applications of same |
| 01/06/2003 | CA2445824A1 Composite particles, derived conjugates, preparation method thereof and applications of same |
| 01/06/2003 | CA2392288A1 Pharmaceutical preparation for the inhalation of antithrombin in anti-inflammatory lung diseases and ards |
| 01/06/2003 | CA2392187A1 Combination preparation for the therapy of immunological diseases |
| 01/05/2003 | CA2392544A1 Natural therapeutic composition for the treatment of wounds and sores |
| 01/05/2003 | CA2392189A1 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents |
| 01/05/2003 | CA2390181A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents |
| 01/05/2003 | CA2352674A1 Natural therapeutic composition for the treatment of wounds and sores |
| 01/03/2003 | WO2003000922A2 Chimeric immunomodulatory compounds and methods of using the same |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000889A2 Identification of ses-1 and the uses of the same |
| 01/03/2003 | WO2003000861A2 Eukaryotic genes involved in adult lifespan regulation |
| 01/03/2003 | WO2003000846A2 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | WO2003000777A2 Multi-arm block copolymers as drug delivery vehicles |
| 01/03/2003 | WO2003000771A1 Block copolymer reduced in impurity content, polymeric carrier, pharmaceutical preparations in polymeric form and process for the preparation of the same |
| 01/03/2003 | WO2003000727A2 Atopy |
| 01/03/2003 | WO2003000717A2 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 01/03/2003 | WO2003000713A1 Nucleoside compounds in hcv |
| 01/03/2003 | WO2003000709A2 Sialic acid derivatives for use as siglec inhibitors |
| 01/03/2003 | WO2003000699A1 Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 01/03/2003 | WO2003000698A1 β-BENZYLOXYASPARTATE DERIVATIVES WITH AMINO GROUP ON BENZENE RING |
| 01/03/2003 | WO2003000696A1 COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE |
| 01/03/2003 | WO2003000695A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 01/03/2003 | WO2003000694A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 01/03/2003 | WO2003000693A1 Imidazotriazines for use as phosphodiesterase inhibitors |
| 01/03/2003 | WO2003000692A2 Oxytocin agonists |
| 01/03/2003 | WO2003000691A1 Carboline derivatives as pdev inhibitors |
| 01/03/2003 | WO2003000689A1 Imidazo`1,2-a!pyridine derivatives for the prophylaxis and treatment of herpes viral infections |
| 01/03/2003 | WO2003000688A1 Azaindoles |
| 01/03/2003 | WO2003000687A1 Tyrosine kinase inhibitors |
| 01/03/2003 | WO2003000684A1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000682A1 (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds |
| 01/03/2003 | WO2003000681A1 Antibacterial having quinolinecarboxamide skeleton |
| 01/03/2003 | WO2003000678A1 Cyanoanthranilamide derivatives and the use thereof as medicaments |